Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Submits Comments to Ohio House Leadership, Opposing HB 248, a Bill Concerning Abuse-Deterrent Opioid Analgesic Drug Products AMCP Submits Comments to Ohio House Leadership, Opposing HB 248, a Bill Concerning Abuse-Deterrent Opioid Analgesic Drug Products 5/19/16 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page OH Sub HB 248.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page